SIRT3 and neoplasm: believe that SIRT3 is a tumor suppressor in B-cell malignancies, activates the SIRT3 pathway, promotes aerobic metabolism and controls reactive oxygen species (ROS), and suppresses the hypoxia-inducing factor-1-independent mechanism that may be a new therapeutic method for the treatment of B-cell malignancies (39).